{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:09:51Z","timestamp":1782274191446,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.antiviral.2020.104879","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T11:25:56Z","timestamp":1599650756000},"page":"104879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A synthetic stigmastane displays antiadenoviral activity and reduces the inflammatory response to viral infection"],"prefix":"10.1016","volume":"183","author":[{"given":"Flavia M.","family":"Michelini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanina B.","family":"Areco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Alch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104879_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1099\/vir.0.056838-0","article-title":"The adenovirus 55 residue E1A protein is a transcriptional activator and binds the unliganded thyroid hormone receptor","volume":"95","author":"Arulsundaram","year":"2014","journal-title":"J. Gen. Virol."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104879_bib2","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1128\/JVI.00469-14","article-title":"Sp100 isoform-specific regulation of human adenovirus 5 gene expression","volume":"88","author":"Berscheminski","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104879_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.virol.2016.12.011","article-title":"Viral exploitation of the MEK\/ERK pathway \u2013 a tale of vaccinia virus and other viruses","volume":"507","author":"Bonjardim","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104879_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/jvi.71.1.398-404.1997","article-title":"Adenovirus infection stimulates the Raf\/MAPK signaling pathway and induces interleukin-8 expression","volume":"71","author":"Bruder","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104879_bib5","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/JVI.02639-14","article-title":"Nuclear import of adenovirus DNA involves direct interaction of Hexon with an N-terminal domain of the nucleoporin Nup214","volume":"89","author":"Cassany","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104879_bib6","first-page":"1","article-title":"Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection","volume":"33","author":"Chen","year":"2013","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104879_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13567-019-0697-0","article-title":"Bovine ephemeral fever virus triggers autophagy enhancing virus replication via upregulation of the Src\/JNK\/AP1 and PI3K\/Akt\/NF-\u03baB pathways and suppression of the PI3K\/Akt\/mTOR pathway","volume":"50","author":"Cheng","year":"2019","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2020.104879_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2020.104879_bib9","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1167\/iovs.03-0560","article-title":"Characterization of a spontaneously immortalized cell line [IOBA-NHC cells] from normal human conjunctiva","volume":"44","author":"Diebold","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2020.104879_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2017.04.024","article-title":"Transmissible gastroenteritis virus infection induces NF-\u03baB activation through RLR-mediated signaling","volume":"507","author":"Ding","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104879_bib11","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/ijms20143427","article-title":"Human DNA virus exploitation of the MAPK-ERK cascade","volume":"20","author":"DuShane","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2020.104879_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ajt.12112","article-title":"Adenovirus in solid organ transplantation","volume":"4","author":"Florescu","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2020.104879_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01623-16","article-title":"Suppression of adenovirus replication by cardiotonic steroids","volume":"91","author":"Grosso","year":"2017","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104879_bib14","first-page":"161","article-title":"HPV: Molecular pathways and targets","volume":"42","author":"Grupta","year":"2018","journal-title":"Curr. Probl. Canc."},{"key":"10.1016\/j.antiviral.2020.104879_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2006.08.041","article-title":"Adenoviral infection induces a multifaceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells","volume":"358","author":"Hartman","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104879_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/fmb.10.162","article-title":"An adenovirus traffic update: from receptor engagement to the nuclear pore","volume":"6","author":"Henaff","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2020.104879_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/hum.2014.001","article-title":"Innate immunity to adenovirus","volume":"25","author":"Hendrickx","year":"2014","journal-title":"Hum. Gene Ther."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104879_bib18","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1002\/jcb.26829","article-title":"Effects of curcumin on NF\u2010\u03baB, AP\u20101, and Wnt\/\u03b2\u2010catenin signaling pathway in hepatitis B virus infection","volume":"119","author":"Hesari","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.antiviral.2020.104879_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.DMIH2-0020-2015","article-title":"Adenovirus","volume":"4","author":"Ison","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.antiviral.2020.104879_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.survophthal.2015.04.001","article-title":"Adenoviral keratoconjunctivitis","volume":"60","author":"Jhanji","year":"2015","journal-title":"Surv. Ophthalmol."},{"issue":"28","key":"10.1016\/j.antiviral.2020.104879_bib21","doi-asserted-by":"crossref","first-page":"16483","DOI":"10.1074\/jbc.270.28.16483","article-title":"The regulation of AP-1 activity by mitogen-activated protein kinases","volume":"270","author":"Karin","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104879_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jac\/dki057","article-title":"Prospects for adenovirus antivirals","volume":"55","author":"Kinchington","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104879_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/nar\/19.3.649","article-title":"E1A dependent up-regulation of cjun\/AP-1 activity","volume":"19","author":"Kitabayashi","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104879_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a dexamethasone 0.1 % drops: a clinical prospective controlled randomized study","volume":"95","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.antiviral.2020.104879_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/OPTH.S207976","article-title":"Management of adenoviral keratoconjunctivitis: challenges and solutions","volume":"14","author":"Labib","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.antiviral.2020.104879_bib26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2020.104879_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0885066616681272","article-title":"Treatment of adenoviral acute respiratory distress syndrome using cidofovir with extracorporeal membrane oxygenation","volume":"32","author":"Lee","year":"2017","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.antiviral.2020.104879_bib28","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1128\/AAC.01311-07","article-title":"Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection","volume":"52","author":"Lenaerts","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104879_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104879_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virusres.2012.12.001","article-title":"Dioscin's antiviral effect in vitro","volume":"172","author":"Liu","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2020.104879_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2008.05.005","article-title":"Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives","volume":"111","author":"Michelini","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104879_bib32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bmc.2012.10.054","article-title":"Immunomodulatory activity of an anti-HSV-1 synthetic stigmastane analog","volume":"21","author":"Michelini","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104879_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbagen.2015.10.024","article-title":"Synthetic stigmastanes with dual antiherpetic and immunomodulating activities inhibit ERK and Akt signaling pathways without binding to glucocorticoid receptors","volume":"1860","author":"Michelini","year":"2016","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.antiviral.2020.104879_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874285801610010004","article-title":"Pre-transplant screening for latent adenovirus in donors and recipients","volume":"10","author":"Piatti","year":"2016","journal-title":"Open Microbiol. J."},{"key":"10.1016\/j.antiviral.2020.104879_bib35","first-page":"2879","article-title":"Specific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis","volume":"15","author":"Rajaiya","year":"2009","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104879_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000313530","article-title":"Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives","volume":"56","author":"Romanutti","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.antiviral.2020.104879_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.antiviral.2014.05.010","article-title":"Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative","volume":"108","author":"Sanchez-Cespedes","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104879_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","article-title":"Herpes keratitis","volume":"32","author":"Rowe","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.antiviral.2020.104879_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/v4050847","article-title":"Latest insights on adenovirus structure and assembly","volume":"4","author":"San Mart\u00edn","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104879_bib40","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/v3081417","article-title":"Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed Hexon","volume":"5","author":"Scherer","year":"2011","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.antiviral.2020.104879_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1128\/jcm.24.2.265-268.1986","article-title":"Alternative cell line for virus isolation","volume":"24","author":"Smith","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104879_bib42","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/emboj\/20.6.1310","article-title":"Adenovirus-activated PKA and p38\/MAPK pathways boost microtubule-mediated nuclear targeting of virus","volume":"20","author":"Suomalainen","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104879_bib43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/JVI.76.4.1559-1568.2002","article-title":"Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10","volume":"76","author":"Tibbles","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104879_bib44","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/ceo.12785","article-title":"Review Herpes simplex virus keratitis\u00a0: an update of the pathogenesis and current treatment with oral and topical antiviral agents","volume":"44","author":"Tsatsos","year":"2016","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.antiviral.2020.104879_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jpids\/pix011","article-title":"Renal toxicity in pediatric patients receiving cidofovir for the treatment of adenovirus infection","volume":"6","author":"Vora","year":"2017","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"10.1016\/j.antiviral.2020.104879_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0966-842X(94)90801-X","article-title":"Adenovirus proteins that subvert host defenses","volume":"2","author":"Wold","year":"1994","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2020.104879_bib47","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1517\/14656566.2015.1083975","article-title":"New drug on the horizon for treating adenovirus","volume":"16","author":"Wold","year":"2015","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422030293X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422030293X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:52Z","timestamp":1759062772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635422030293X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":47,"alternative-id":["S016635422030293X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104879","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A synthetic stigmastane displays antiadenoviral activity and reduces the inflammatory response to viral infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104879"}}